Glutathione
- Generic Name
- Glutathione
- Drug Type
- Small Molecule
- Chemical Formula
- C10H17N3O6S
- CAS Number
- 70-18-8
- Unique Ingredient Identifier
- GAN16C9B8O
- Background
A tripeptide with many roles in cells. It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes, is involved in protein disulfide bond rearrangement and reduces peroxides.
- Indication
For nutritional supplementation, also for treating dietary shortage or imbalance
- Associated Conditions
- Hangover, Nerve Disorders, Neuropathy
Combined Drug Approach to Prevent Ischemia-reperfusion Injury During Transplantation of Livers (CAPITL)
- Conditions
- Reperfusion Injury
- Interventions
- Drug: Antithrombin-IIIDrug: ApotransferrinDrug: C1-Inhibitor
- First Posted Date
- 2014-09-26
- Last Posted Date
- 2024-08-23
- Lead Sponsor
- Universitaire Ziekenhuizen KU Leuven
- Target Recruit Count
- 143
- Registration Number
- NCT02251041
- Locations
- 🇧🇪
University Hospitals Leuven, Leuven, Belgium
Inhaled Glutathione (GSH) Versus Placebo in Cystic Fibrosis
- Conditions
- Cystic Fibrosis
- Interventions
- Drug: Physiological solution
- First Posted Date
- 2011-10-12
- Last Posted Date
- 2011-10-13
- Lead Sponsor
- Serafino A. Marsico
- Target Recruit Count
- 150
- Registration Number
- NCT01450267
- Locations
- 🇮🇹
Ospedale Monaldi, Azienda Ospedaliera Universitaria Federico II, Naples, Italy
Intranasal Glutathione in Parkinson's Disease
- Conditions
- Parkinson's Disease (PD)
- Interventions
- Drug: Saline Intranasal Delivery
- First Posted Date
- 2011-07-21
- Last Posted Date
- 2017-07-31
- Lead Sponsor
- Bastyr University
- Target Recruit Count
- 34
- Registration Number
- NCT01398748
- Locations
- 🇺🇸
Bastyr Clinical Research Center, Kenmore, Washington, United States
Glutathione (GSH) In The Treatment of Parkinson's Disease
- Conditions
- Parkinson's Disease
- First Posted Date
- 2010-08-09
- Last Posted Date
- 2010-08-09
- Lead Sponsor
- University of South Florida
- Target Recruit Count
- 20
- Registration Number
- NCT01177319
- Locations
- 🇺🇸
USF Parkinson's Disease and Movement Disorders Center, Tampa, Florida, United States
Polymorphism of Oxidative Stress Genes in the Pathogenesis and Antioxidant Prevention of Contrast Induced Nephropathy
- Conditions
- NephropathyOxidative Stress
- Interventions
- Drug: saline
- First Posted Date
- 2010-06-11
- Last Posted Date
- 2011-06-27
- Lead Sponsor
- Huashan Hospital
- Target Recruit Count
- 1000
- Registration Number
- NCT01142024
- Locations
- 🇨🇳
Department of cardiology and nephrology,Huashan Hospital, Shanghai, Shanghai, China
Oral Glutathione Supplementation on the Levels of Blood Glutathione
- Conditions
- Healthy Adults
- Interventions
- First Posted Date
- 2010-01-07
- Last Posted Date
- 2022-09-06
- Lead Sponsor
- Milton S. Hershey Medical Center
- Target Recruit Count
- 61
- Registration Number
- NCT01044277
- Locations
- 🇺🇸
Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States
Role of Oral Glutathione in Skin Whitening
- First Posted Date
- 2009-11-18
- Last Posted Date
- 2009-11-18
- Lead Sponsor
- Chulalongkorn University
- Target Recruit Count
- 60
- Registration Number
- NCT01016080
- Locations
- 🇹ðŸ‡
King Chulalongkorn Memorial Hospital, Bangkok, Thailand
Study of Glutathione, Vitamin C and Cysteine in Children With Autism and Severe Behavior Problems
- Conditions
- Severe Behavior DisorderAutism
- Interventions
- First Posted Date
- 2009-04-29
- Last Posted Date
- 2016-12-07
- Lead Sponsor
- University of Louisville
- Target Recruit Count
- 24
- Registration Number
- NCT00889538
- Locations
- 🇺🇸
KCPCRU, Louisville, Kentucky, United States
Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer
- Conditions
- Stage III Pancreatic CancerAdenocarincoma of PancreasStage IVB Pancreatic CancerStage IVA Pancreatic Cancer
- First Posted Date
- 2006-05-09
- Last Posted Date
- 2007-05-08
- Lead Sponsor
- Seattle Cancer Treatment and Wellness Center
- Target Recruit Count
- 80
- Registration Number
- NCT00323583
- Locations
- 🇺🇸
Seattle Cancer Treatment and Wellness Center, Seattle, Washington, United States
RayGel-An Alternative for Skin Care During External Beam Radiation
- First Posted Date
- 2005-12-16
- Last Posted Date
- 2013-08-28
- Lead Sponsor
- Nathalie Johnson
- Target Recruit Count
- 150
- Registration Number
- NCT00266331
- Locations
- 🇺🇸
Legacy Health System, Portland, Oregon, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.